Showing results (81-90 of 401) with videos related to
Sort By:
Pageof 41
The Lancet. Diabetes & Endocrinology|February 1, 2024
A proposed clinical classification for pituitary neoplasms to guide therapy and prognosisKen K Y Ho, Maria Fleseriu, John Wass, et al.Drug Design, Development and Therapy|January 27, 2016
Pasireotide: a novel treatment for patients with acromegalyDaniel Cuevas-Ramos, Maria FleseriuEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 24, 2009
"Relative" adrenal insufficiency in critical illnessMaria Fleseriu, D Lynn LoriauxCurrent Opinion in Endocrinology, Diabetes, and Obesity|August 6, 2009
Relative adrenal insufficiencyDonald L Loriaux, Maria FleseriuEndocrine|November 30, 2012
Mifepristone: is there a place in the treatment of Cushing's disease?John D Carmichael, Maria FleseriuThe Journal of Endocrinology|August 20, 2014
Treatment of Cushing's disease: a mechanistic updateDaniel Cuevas-Ramos, Maria FleseriuPituitary|May 31, 2024
Acromegaly and COVID-19, lessons, and new opportunitiesElena V Varlamov, Maria FleseriuPlos One|August 23, 2011
PTTG1 attenuates drug-induced cellular senescenceYunguang Tong, Weijiang Zhao, Cuiqi Zhou, et al.The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiencyVivien S Bonert, Janet D Elashoff, Philip Barnett, et al.Nature Medicine|October 16, 2002
Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomasAnthony P Heaney, Manory Fernando, William H Yong, et al.Pageof 41